|
|
Promyelocytic Leukemia
|
|
Promyelocytic Leukemia
ZIOPHARM Oncology Announces ZIO-101 Data Published in Blood Nov 21, 2005
...trioxide, an inorganic compound, and organic arsenic derivative S-dimethylarsino-glutathione (SGLU; ZIO-101) in NB4 acute promyelocytic leukemia (APL) cells ...
- Business Wire (press release),
Ziopharm's anticancer drug shows potential Nov 18, 2005
...approximately 25 times higher than the currently approved dose for arsenic trioxide, an inorganic arsenic currently approved for acute promyelocytic leukemia. ...
- Pharmaceutical Business Review
ZIOPHARM Oncology Announces ZIO-101 Phase I Data Presented at AACR ... Nov 16, 2005
...less toxic at significantly higher doses as compared to arsenic trioxide, an inorganic arsenic currently approved for acute promyelocytic leukemia (APL)," said ...
- Genetic Engineering News,
Siblings stay strong Nov 13, 2005
...(He) said, 'I got leukemia,'" Sprong, 45, said. "Richie," as he is affectionately known by his family, was diagnosed with acute promyelocytic leukemia. ...
- Marion Chronicle Tribune,
Conference examines role of chromosome changes in cancer Oct 28, 2005
...to specific malignancies, such as the 14;18 translocation seen in follicular lymphoma, and the 15;17 translocation that causes acute promyelocytic leukemia (APL ...
- EurekAlert (press release),
Bhupathi, Hantuchova in mixed doubles final Sep 9, 2005
Bhupathi and Hantuchova may have taken the early lead when Morariu, who has battled back from promyelocytic leukemia after being forced out of the tour for ...
- Times of India
Cephalon concludes leukemia treatment dealJul 19, 2005
...in the United States and Europe in 2000 and 2002, respectively, for the treatment of patients with relapsed or refractory acute promyelocytic leukemia, a life ...
- Philadelphia Business Journal
Cephalon, Inc. Completes Acquisition of TRISENOX From Cell ...Jul 19, 2005
...in the United States and Europe in 2000 and 2002, respectively, for the treatment of patients with relapsed or refractory acute promyelocytic leukemia (APL), a ...
- PharmaLive.com
Cell Therapeutics completes sale of TrisenoxJul 19, 2005
It was approved in the United States in 2000 and in Europe in 2002 for treatment of patients with relapsed or refractory acute promyelocytic leukemia. ...
- Puget Sound Business Journal
This page is updated on a monthly basis if relevant articles are available. If you are looking for further information on
Promyelocytic Leukemia
you may want to try searching the Internet using the Google search box below.
|
|
|
